Mechanism for benzyl alcohol‐induced aggregation of recombinant human interleukin‐1 receptor antagonist in aqueous solution

Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin‐1 receptor antagonist (rhIL‐1ra) in aqueous solution. The loss of native monomer during incubation at 37°C was determined by analysis of sample aliquots with size exclusion high...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 93; no. 12; pp. 3076 - 3089
Main Authors Zhang, Ye, Roy, Shouvik, Jones, Latoya S., Krishnan, Sampathkumar, Kerwin, Bruce A., Chang, Byeong S., Manning, Mark C., Randolph, Theodore W., Carpenter, John F.
Format Journal Article
LanguageEnglish
Published Hoboken Elsevier Inc 01.12.2004
Wiley Subscription Services, Inc., A Wiley Company
Wiley
American Pharmaceutical Association
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin‐1 receptor antagonist (rhIL‐1ra) in aqueous solution. The loss of native monomer during incubation at 37°C was determined by analysis of sample aliquots with size exclusion high performance liquid chromatography (SE‐HPLC). Benzyl alcohol caused minor perturbation of the tertiary structure of the protein without changing its secondary structure, documenting that the preservative caused a minor shift in the protein molecular population toward partially unfolded species. Consistent with this conclusion, in the presence of benzyl alcohol the rate of H‐D exchange was accelerated and the fluorescence of 1‐anilinonaphthalene‐8‐sulfonic acid in the presence of rhIL1ra was increased. Benzyl alcohol did not alter the free energy of unfolding based on unfolding experiments in urea or guanidine HCl. With differential scanning calorimetry it was determined that benzyl alcohol reduced the apparent Tm of rhIL‐1ra, but this effect occurred because the preservative lowered the temperature at which the protein aggregated during heating. Isothermal calorimetry documented that the interaction of benzyl alcohol with rhIL‐1ra is relatively weak and hydrophobically driven. Thus, benzyl alcohol accelerates protein aggregation by binding to the protein and favoring an increase in the level of partially unfolded, aggregation‐competent species. Sucrose partially inhibited benzyl alcohol‐induced aggregation and tertiary structural change. Sucrose is preferentially excluded from the surface of the protein, favoring most compact native state species over expanded aggregation‐prone forms. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:3076–3089, 2004
AbstractList Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) in aqueous solution. The loss of native monomer during incubation at 37 degrees C was determined by analysis of sample aliquots with size exclusion high performance liquid chromatography (SE-HPLC). Benzyl alcohol caused minor perturbation of the tertiary structure of the protein without changing its secondary structure, documenting that the preservative caused a minor shift in the protein molecular population toward partially unfolded species. Consistent with this conclusion, in the presence of benzyl alcohol the rate of H-D exchange was accelerated and the fluorescence of 1-anilinonaphthalene-8-sulfonic acid in the presence of rhIL1ra was increased. Benzyl alcohol did not alter the free energy of unfolding based on unfolding experiments in urea or guanidine HCl. With differential scanning calorimetry it was determined that benzyl alcohol reduced the apparent Tm of rhIL-1ra, but this effect occurred because the preservative lowered the temperature at which the protein aggregated during heating. Isothermal calorimetry documented that the interaction of benzyl alcohol with rhIL-1ra is relatively weak and hydrophobically driven. Thus, benzyl alcohol accelerates protein aggregation by binding to the protein and favoring an increase in the level of partially unfolded, aggregation-competent species. Sucrose partially inhibited benzyl alcohol-induced aggregation and tertiary structural change. Sucrose is preferentially excluded from the surface of the protein, favoring most compact native state species over expanded aggregation-prone forms.
Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin‐1 receptor antagonist (rhIL‐1ra) in aqueous solution. The loss of native monomer during incubation at 37°C was determined by analysis of sample aliquots with size exclusion high performance liquid chromatography (SE‐HPLC). Benzyl alcohol caused minor perturbation of the tertiary structure of the protein without changing its secondary structure, documenting that the preservative caused a minor shift in the protein molecular population toward partially unfolded species. Consistent with this conclusion, in the presence of benzyl alcohol the rate of H‐D exchange was accelerated and the fluorescence of 1‐anilinonaphthalene‐8‐sulfonic acid in the presence of rhIL1ra was increased. Benzyl alcohol did not alter the free energy of unfolding based on unfolding experiments in urea or guanidine HCl. With differential scanning calorimetry it was determined that benzyl alcohol reduced the apparent Tm of rhIL‐1ra, but this effect occurred because the preservative lowered the temperature at which the protein aggregated during heating. Isothermal calorimetry documented that the interaction of benzyl alcohol with rhIL‐1ra is relatively weak and hydrophobically driven. Thus, benzyl alcohol accelerates protein aggregation by binding to the protein and favoring an increase in the level of partially unfolded, aggregation‐competent species. Sucrose partially inhibited benzyl alcohol‐induced aggregation and tertiary structural change. Sucrose is preferentially excluded from the surface of the protein, favoring most compact native state species over expanded aggregation‐prone forms. © 2004 Wiley‐Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:3076–3089, 2004
Author Jones, Latoya S.
Chang, Byeong S.
Zhang, Ye
Krishnan, Sampathkumar
Carpenter, John F.
Kerwin, Bruce A.
Randolph, Theodore W.
Manning, Mark C.
Roy, Shouvik
Author_xml – sequence: 1
  givenname: Ye
  surname: Zhang
  fullname: Zhang, Ye
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
– sequence: 2
  givenname: Shouvik
  surname: Roy
  fullname: Roy, Shouvik
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
– sequence: 3
  givenname: Latoya S.
  surname: Jones
  fullname: Jones, Latoya S.
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
– sequence: 4
  givenname: Sampathkumar
  surname: Krishnan
  fullname: Krishnan, Sampathkumar
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
– sequence: 5
  givenname: Bruce A.
  surname: Kerwin
  fullname: Kerwin, Bruce A.
  organization: Amgen, Inc., Thousand Oaks, California 91320
– sequence: 6
  givenname: Byeong S.
  surname: Chang
  fullname: Chang, Byeong S.
  organization: Amgen, Inc., Thousand Oaks, California 91320
– sequence: 7
  givenname: Mark C.
  surname: Manning
  fullname: Manning, Mark C.
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
– sequence: 8
  givenname: Theodore W.
  surname: Randolph
  fullname: Randolph, Theodore W.
  organization: Department of Chemical and Biological Engineering, University of Colorado, Boulder, Colorado 80309
– sequence: 9
  givenname: John F.
  surname: Carpenter
  fullname: Carpenter, John F.
  email: john.carpenter@uchsc.edu
  organization: Department of Pharmaceutical Science, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16318710$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/15514986$$D View this record in MEDLINE/PubMed
BookMark eNp1kc1uEzEUhS1URNPCghdA3oDEYlp7bM_PElWQgMqPFBBLy-O5Ttx67NSeAcIGHoFn5ElwSKAbkBd34e-ee8-5J-jIBw8IPaTkjBJSnl9t0llJStreQTMqSlJUhNZHaJb_yoIJ3h6jk5SuCCEVEeIeOqZCUN421Qx9ew16rbxNAzYh4g78163DyumwDu7n9x_W95OGHqvVKsJKjTZ4HAyOoMPQWa_8iNfToDy2foToYLq2PrfRHQGbMUtmRK1CnjBmBqubCcKUcApu2ondR3eNcgkeHOop-vDi-fuLRXH5dv7y4tlloTkTbWFaoD1pKt1zbmhnSCN4rzolRFv2XUlpbbpsj7Yiv4aJ2nDelgxawrmoSMVO0ZO97iaGvEIa5WCTBueU3-0jq5pwRliTwad7UMeQUgQjN9EOKm4lJXKXtsxpy99pZ_bRQXTqBuhvyUO8GXh8AFTSypmovLbplqsYbWpKMne-5z5bB9v_T5Sv3i3_jC72HTlX-PK3Q8XrbIXVQn58M5fzxWK55PVclplnex5yyJ8sRJm0BZ9Pa_OlRtkH-w-DvwBWfbxG
CODEN JPMSAE
CitedBy_id crossref_primary_10_1002_jps_24105
crossref_primary_10_1002_prot_22778
crossref_primary_10_1110_ps_051490205
crossref_primary_10_1517_17425240903199143
crossref_primary_10_1002_jps_22601
crossref_primary_10_1186_s40360_015_0010_4
crossref_primary_10_1002_jps_22129
crossref_primary_10_1002_jps_22426
crossref_primary_10_1021_bi901570k
crossref_primary_10_1002_bit_21398
crossref_primary_10_1016_j_xphs_2018_11_043
crossref_primary_10_1002_jps_20488
crossref_primary_10_1021_acs_molpharmaceut_2c00449
crossref_primary_10_1002_jps_24384
crossref_primary_10_1039_D1CB00067E
crossref_primary_10_1002_jps_20340
crossref_primary_10_1002_jps_20619
crossref_primary_10_1016_j_ijpharm_2014_06_044
crossref_primary_10_1021_acs_jmedchem_8b00292
crossref_primary_10_1016_j_xphs_2017_02_007
crossref_primary_10_1002_jps_20976
crossref_primary_10_1111_j_2042_7158_2011_01288_x
crossref_primary_10_1016_j_ejpb_2014_03_010
crossref_primary_10_1016_j_xphs_2021_11_001
crossref_primary_10_3390_pharmaceutics15020563
crossref_primary_10_1007_s11095_006_9098_y
crossref_primary_10_3109_10837450_2013_775158
crossref_primary_10_1016_j_addr_2011_07_006
crossref_primary_10_3390_vaccines12060580
crossref_primary_10_1002_jps_20258
crossref_primary_10_1098_rsfs_2017_0030
crossref_primary_10_1002_jps_23362
crossref_primary_10_1002_jps_24253
crossref_primary_10_1016_j_ejpb_2008_09_012
crossref_primary_10_1110_ps_073332408
crossref_primary_10_1016_j_xphs_2022_07_019
crossref_primary_10_1016_j_ijbiomac_2017_09_072
crossref_primary_10_1021_bi5002163
crossref_primary_10_1021_acs_molpharmaceut_0c01028
crossref_primary_10_1021_bi900853v
crossref_primary_10_1016_j_xphs_2020_11_039
crossref_primary_10_1002_jps_21719
Cites_doi 10.1016/S0021-9258(19)68947-7
10.1073/pnas.94.22.11917
10.2337/diab.39.6.728
10.1021/bi00303a044
10.1021/bi00138a001
10.1023/A:1018940907187
10.1023/A:1012101027814
10.1074/jbc.275.3.1570
10.1001/archneur.1993.00540020013009
10.1146/annurev.bb.22.060193.000435
10.1111/j.1432-1033.1995.tb20209.x
10.1016/S0041-0101(97)00101-3
10.1006/abio.1994.1499
10.1177/106002809102500603
10.1006/jcis.1998.5687
10.1016/S1359-0278(98)00002-9
10.1021/bi00465a022
10.1074/jbc.M212540200
10.1016/S0021-9258(18)99957-6
10.1016/0301-4622(96)00009-9
10.1021/js9801384
10.1110/ps.0242603
10.1016/S0065-3233(08)60656-7
10.1208/ps050208
10.1210/jcem-51-4-691
10.1002/jps.10589
10.1016/S0092-8674(00)80143-9
10.3109/10409237409105445
10.1016/0003-2697(89)90213-3
10.1023/A:1018893115557
10.1038/13273
10.1016/0378-5173(96)04577-2
10.1046/j.1365-2516.2002.00635.x
10.1016/S0006-3495(96)79534-6
10.1023/A:1012190120061
10.1023/A:1011902215383
10.1002/(SICI)1096-8652(199909)62:1<13::AID-AJH3>3.0.CO;2-X
10.1021/bi012006m
10.1074/jbc.M202492200
10.1023/A:1025771421906
10.1073/pnas.95.24.14142
10.1073/pnas.131194798
10.1074/jbc.M007766200
10.1016/0011-2240(90)90017-X
ContentType Journal Article
Copyright 2004 Wiley‐Liss, Inc.
Copyright © 2004 Wiley‐Liss, Inc.
2005 INIST-CNRS
(c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association
Copyright_xml – notice: 2004 Wiley‐Liss, Inc.
– notice: Copyright © 2004 Wiley‐Liss, Inc.
– notice: 2005 INIST-CNRS
– notice: (c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association
DBID BSCLL
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1002/jps.20219
DatabaseName Istex
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-6017
EndPage 3089
ExternalDocumentID 10_1002_jps_20219
15514986
16318710
JPS20219
ark_67375_WNG_GHHSS47G_2
S0022354916393121
Genre article
Research Support, U.S. Gov't, Non-P.H.S
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-~X
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1CY
1L6
1OC
1ZS
31~
33P
36B
3O-
3WU
4.4
457
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
A8Z
AAEVG
AAHHS
AAIAV
AAKUH
AALRI
AAOIN
AAONW
AAXUO
AAYOK
AAZKR
ABCQN
ABEML
ABFRF
ABIJN
ABJNI
ABMAC
ABOCM
ABPVW
ABWRO
ACBWZ
ACCFJ
ACGFO
ACGFS
ACIWK
ACPRK
ACSCC
ACXME
ACXQS
ADBBV
ADIZJ
AEEZP
AEFWE
AEIMD
AENEX
AEQDE
AEUQT
AFBPY
AFFNX
AFRAH
AFTJW
AFZJQ
AGHFR
AI.
AITUG
AIWBW
AJAOE
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
AMBMR
AMRAJ
ATUGU
AZBYB
BAFTC
BDRZF
BFHJK
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
ESTFP
F00
F01
F04
F5P
FDB
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HHY
HHZ
HOLLA
HVGLF
HX~
HZ~
IX1
J0M
JPC
KQQ
L7B
LAW
LC2
LC3
LH4
LP6
LP7
LSO
LW6
M41
M6Q
MK0
MK4
N04
N05
N9A
NF~
NNB
O66
O9-
P2P
P2X
P4D
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SSZ
SUPJJ
SV3
UB1
UKR
UNMZH
V2E
V8K
VH1
W8V
W99
WBFHL
WH7
WIB
WJL
WQJ
WRC
WUP
WWP
WYUIH
XG1
XPP
XV2
Y6R
YCJ
ZE2
ZGI
ZXP
~IA
~WT
ABPTK
BSCLL
ADVLN
AKRWK
OIG
IQODW
1OB
AFJKZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4359-f9e1d086cd44f1bf0854daba5592db2117fb0001959598357f44923e904456063
IEDL.DBID DR2
ISSN 0022-3549
IngestDate Fri Aug 16 21:26:11 EDT 2024
Thu Sep 26 17:29:11 EDT 2024
Sat Sep 28 07:48:57 EDT 2024
Tue Sep 17 11:18:05 EDT 2024
Sat Aug 24 00:57:44 EDT 2024
Wed Jan 17 05:01:26 EST 2024
Fri Feb 23 02:28:46 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords benzyl alcohol
sucrose
protein aggregation
Aggregation
Human
Pharmaceutical technology
Sucrose
Interleukin 1
Benzyl alcohol
Antagonist
Aqueous solution
Mechanism of action
Protein
Biological receptor
Language English
License CC BY 4.0
(c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4359-f9e1d086cd44f1bf0854daba5592db2117fb0001959598357f44923e904456063
Notes ArticleID:JPS20219
istex:2CF96BDEC54A82FA94DC39CD8305514A8120F23F
ark:/67375/WNG-GHHSS47G-2
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 15514986
PQID 67043038
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_67043038
crossref_primary_10_1002_jps_20219
pubmed_primary_15514986
pascalfrancis_primary_16318710
wiley_primary_10_1002_jps_20219_JPS20219
istex_primary_ark_67375_WNG_GHHSS47G_2
elsevier_sciencedirect_doi_10_1002_jps_20219
PublicationCentury 2000
PublicationDate December 2004
PublicationDateYYYYMMDD 2004-12-01
PublicationDate_xml – month: 12
  year: 2004
  text: December 2004
PublicationDecade 2000
PublicationPlace Hoboken
PublicationPlace_xml – name: Hoboken
– name: Washington, DC
– name: Hoboken, NJ
– name: United States
PublicationTitle Journal of pharmaceutical sciences
PublicationTitleAlternate J. Pharm. Sci
PublicationYear 2004
Publisher Elsevier Inc
Wiley Subscription Services, Inc., A Wiley Company
Wiley
American Pharmaceutical Association
Publisher_xml – name: Elsevier Inc
– name: Wiley Subscription Services, Inc., A Wiley Company
– name: American Pharmaceutical Association
– name: Wiley
References Chi, Krishnan, Randolph, Carpenter (bb0085) 2003; 20
Mach, Middaugh (bb0210) 1994; 222
Wiseman, Williston, Brandts, Lin (bb0220) 1989; 179
Kim, Jones, Dong, Kendrick, Chang, Manning, Randolph, Carpenter (bb0180) 2003; 12
Jorgensen, Mortensen, Jorgensen (bb0015) 1991; 25
Lam, Patapoff, Nguyen (bb0045) 1997; 14
Gupta, Kaisheva (bb0060) 2003; 5
Tan, Shah, Leister, Kozick, Pasciak, Vanderlaan, Yu, Patel (bb0030) 1993; 10
Tobler, Holmes, Cromwell, Fernandez (bb0135) 2004; 93
Stockman, Scahill, Roy, Ulrich, Strakalaitis, Brunner, Yem, Deibel (bb0195) 1992; 31
Batorova, Martinowitz (bb0025) 2002; 8
Remmele, Nightlinger, Srinivasan, Gombotz (bb0050) 1998; 15
Arakawa, Carpenter, Kita, Crowe (bb0235) 1990; 27
Akers (bb0010) 1984; 8
Kendrick, Carpenter, Cleland, Randolph (bb0115) 1998; 95
Krishnan, Chi, Webb, Chang, Shan, Goldenberg, Manning, Randolph, Carpenter (bb0090) 2002; 41
Fink (bb0100) 1998; 3
Huyghues‐Despointes, Scholtz, Pace (bb0175) 1999; 6
Strickland (bb0185) 1974; 2
Schreuder, Rondeau, Tardif, Soffientini, Sarubbi, Akeson, Bowlin, Yanofsky, Barrett (bb0205) 1995; 227
Bijma, Rank, Engberts (bb0225) 1998; 205
Timasheff (bb0155) 1993; 22
Belgaumi, Patrick, Deitcher (bb0020) 1999; 62
Kim, Randolph, Stevens, Carpenter (bb0130) 2002; 277
Webb, Webb, Cleland, Carpenter, Randolph (bb0145) 2001; 98
Pace, Shirley, Thomson (bb0190) 1989
Vigers, Caffes, Evans, Thompson, Eisenberg, Brandhuber (bb0200) 1994; 269
Wetzel (bb0095) 1996; 86
Kendrick, Chang, Arakawa, Peterson, Randolph, Manning, Carpenter (bb0105) 1997; 94
Dong, Huang, Caughey (bb0165) 1990; 29
Kendrick, Randolph, Cleland, Lam, Nguyen, Manning, Carpenter (bb0120) 1998; 87
Kim, Wall, Meyer, Murphy, Randolph, Manning, Solomon, Carpenter (bb0125) 2000; 275
Uversky, Winter, Lober (bb0215) 1996; 60
Ratner, Phillips, Steiner (bb0070) 1990; 39
Rodrigues‐Silva, Antunes, Velarde, Santoro (bb0055) 1999; 37
Ragone, Colonna, Balestrieri, Servillo, Irace (bb0170) 1984; 23
Maa, Hsu (bb0035) 1996; 140
Timasheff (bb0230) 1998; 51
Kim, Cape, Chi, Raffen, Wilkins‐Stevens, Stevens, Manning, Randolph, Solomon, Carpenter (bb0160) 2001; 276
Lee, Timasheff (bb0150) 1981; 256
Fransson, Hallen, Florin‐Robertsson (bb0040) 1997; 14
Chang, Beauvais, Arakawa, Narhi, Dong, Aparisio, Carpenter (bb0140) 1996; 71
Moore, Leppert (bb0065) 1980; 51
Thornton, Ballow (bb0075) 1993; 50
Narhi, Philo, Sun, Chang, Arakawa (bb0080) 1999; 16
Kim, Randolph, Manning, Stevens, Carpenter (bb0110) 2003; 278
Stockman BJ, Scahill TA, Roy M, Ulrich EL, Strakalaitis NA, Brunner DP, Yem AW, Deibel MR Jr. 1992. Secondary structure and topology of interleukin-1 receptor antagonist protein determined by heteronuclear three-dimensional NMR spectroscopy. Biochemistry 31: 5237-5245.
Fransson J, Hallen D, Florin-Robertsson E. 1997. Solvent effects on the solubility and physical stability of human insulin-like growth factor I. Pharm Res 14: 606-612.
Timasheff SN. 1998. Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated. Adv Protein Chem 51: 355-432.
Batorova A, Martinowitz U. 2002. Continuous infusion of coagulation factors. Haemophilia 8: 170-177.
Tan EL, Shah HS, Leister KJ, Kozick LM, Pasciak P, Vanderlaan RK, Yu CD, Patel B. 1993. Transforming growth factor-alpha (TGF-alpha) in a semisolid dosage form: Preservative and vehicle selection. Pharm Res 10: 1238-1242.
Tobler SA, Holmes BW, Cromwell MEM, Fernandez EJ. 2004. Benzyl alcohol-induced destabilization of interferon-γ: A study by hydrogen-deuterium isotope exchange. J Pharm Sci 93: 1605-1617.
Chi EY, Krishnan S, Randolph TW, Carpenter JF. 2003. Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation. Pharm Res 20: 1325-1336.
Remmele RL Jr, Nightlinger NS, Srinivasan S, Gombotz WR. 1998. Interleukin-1 receptor (IL-1R) liquid formulation development using differential scanning calorimentry. Pharm Res 15: 200-208.
Fink AL. 1998. Protein aggregation: Folding aggregates, inclusion bodies and amyloid. Fold Des 3: R9-R23.
Kim YS, Jones LS, Dong A, Kendrick BS, Chang BS, Manning MC, Randolph TW, Carpenter JF. 2003. Effects of sucrose on conformational equilibria and fluctuations within the native-state ensemble of proteins. Protein Sci 12: 1252-1261.
Kim YS, Cape SP, Chi E, Raffen R, Wilkins-Stevens P, Stevens FJ, Manning MC, Randolph TW, Solomon A, Carpenter JF. 2001. Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains. J Biol Chem 276: 1626-1633.
Belgaumi AF, Patrick CC, Deitcher SR. 1999. Stability and sterility of a recombinant Factor VIII concentrate prepared for continuous infusion administration. Am J Hematol 62: 13-18.
Wiseman T, Williston S, Brandts JF, Lin LN. 1989. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal Biochem 179: 131-137.
Kim YS, Wall JS, Meyer J, Murphy C, Randolph TW, Manning MC, Solomon A, Carpenter JF. 2000. Thermodynamic modulation of light chain amyloid fibril formation. J Biol Chem 275: 1570-1574.
Ratner RE, Phillips TM, Steiner M. 1990. Persistent cutaneous insulin allergy resulting from high-molecular weight insulin aggregates. Diabetes 39: 728-733.
Krishnan S, Chi EY, Webb JN, Chang BS, Shan D, Goldenberg M, Manning MC, Randolph TW, Carpenter JF. 2002. Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition. Biochemistry 41: 6422-6431.
Kim YS, Randolph TW, Stevens FJ, Carpenter JF. 2002. Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein: Insights into transition states from pressure, temperature and co-solute studies. J Biol Chem 277: 27240-27246.
Vigers GP, Caffes P, Evans RJ, Thompson RC, Eisenberg SP, Brandhuber BJ. 1994. X-ray structure of interleukin-1 receptor antagonist at 2.0-A resolution. J Biol Chem 269: 12874-12879.
Chang BS, Beauvais RM, Arakawa T, Narhi LO, Dong A, Aparisio DI, Carpenter JF. 1996. Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution. Biophys J 71: 3399-3406.
Lam XM, Patapoff TW, Nguyen TH. 1997. The effect of benzyl alcohol on recombinant human interferon-γ. Pharm Res 14: 725-729.
Timasheff SN. 1993. The control of protein stability and association by weak interactions with water: How do solvents affect these processes? Annu Rev Biophys Biomol Struct 22: 67-97.
Uversky VN, Winter S, Lober G. 1996. Use of fluorescence decay times of 8-ANS-protein complexes to study the conformational transitions in proteins which unfold through the molten globule state. Biophys Chem 60: 79-88.
Huyghues-Despointes BMP, Scholtz JM, Pace CN. 1999. Protein conformational stabilities can be determined from hydrogen exchange rates. Nat Struct Biol 6: 910-912.
Kendrick BS, Chang BS, Arakawa T, Peterson B, Randolph TW, Manning MC, Carpenter JF. 1997. Preferential exclusion of sucrose from recombinant interleukin-1 receptor antagonist: role in restricted conformational mobility and compaction of native state. Proc Natl Acad Sci USA 94: 11917-11922.
Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW. 1995. Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline. Eur J Biochem 227: 838-847.
Akers MJ. 1984. Considerations in selecting antimicrobial agents for parenteral product development. Pharm Technol 8: 36-46.
Gupta S, Kaisheva E. 2003. Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques. AAPS PharmSci 5: E8.
Thornton CA, Ballow M. 1993. Safety of intravenous immunoglobulin. Arch Neurol 50: 135-136.
Narhi LO, Philo JS, Sun B, Chang BS, Arakawa T. 1999. Reversibility of heat-induced denaturation of the recombinant human megakaryocyte growth and development factor. Pharm Res 16: 799-807.
Kendrick BS, Randolph TW, Cleland J, Lam X, Nguyen T, Manning MC, Carpenter JF. 1998. Aggregation of recombinant human interferon-gamma: Kinetics and structural transitions. J Pharm Sci 87: 1069-1080.
Arakawa T, Carpenter JF, Kita YA, Crowe JH. 1990. The basis for toxicity of certain cryoprotectants: A hypothesis. Cryobiology 27: 401-415.
Webb JN, Webb SD, Cleland JL, Carpenter JF, Randolph TW. 2001. Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ. Proc Natl Acad Sci USA 98: 7259-7264.
Mach H, Middaugh CR. 1994. Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near-ultraviolet second-derivative spectroscopy. Anal Biochem 222: 323-331.
Moore WV, Leppert P. 1980. Role of aggregated human growth hormone (Hgh) in development of antibodies to Hgh. J Clin Endocrin Metab 51: 691-697.
Kim YS, Randolph TW, Manning MC, Stevens FJ, Carpenter JF. 2003. Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation. J Biol Chem 278: 10842-10850.
Wetzel R. 1996. For protein misassembly, it's the "I" decade. Cell 86: 699-702.
Dong A, Huang P, Caughey WS. 1990. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29: 3303-3308.
Kendrick BS, Carpenter JF, Cleland JL, Randolph TW. 1998. A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. Proc Natl Acad Sci USA 95: 14142-14146.
Jorgensen JT, Mortensen HB, Jorgensen JO. 1991. Patient acceptance of Nordiject: A new drug delivery system for growth hormone. DICP: Ann Pharmacother 25: 585-588.
Strickland EH. 1974. Aromatic contributions to circular dichroism spectra of proteins. CRC Crit Rev Biochem 2: 113-175.
Bijma K, Rank E, Engberts JBFN. 1998. Effect of counterion structure on micellar growth of alkylpyridinium surfactants in aqueous solution. J Colloid Interface Sci 205: 245-256.
Maa YF, Hsu CC. 1996. Aggregation of recombinant human growth hormone induced by phenolic compounds. Int J Pharm Sci 140: 155-168.
Lee JC, Timasheff SN. 1981. The stabilization of proteins by sucrose. J Biol Chem 256: 7193-7201.
Rodrigues-Silva R, Antunes GFC, Velarde DT, Santoro MM. 1999. Thermal stability studies of hyperimmune horse antivenoms. Toxicon 37: 33-45.
Ragone R, Colonna G, Balestrieri C, Servillo L, Irace G. 1984. Determination of tyrosine exposure in proteins by second-derivative spectroscopy. Biochemistry 23: 1871-1875.
1989; 179
1990; 39
1993; 22
1984; 23
2002; 8
2002; 277
1996; 140
1996; 71
2000; 275
1999; 62
1992; 31
2003; 278
1998; 87
1999; 6
1974; 2
2003; 12
2001; 276
1994; 222
1998; 15
1997; 94
1991; 25
2004; 93
1994; 269
2002; 41
1981; 256
1993; 50
1990; 27
1980; 51
1990; 29
1984; 8
1993; 10
1997; 14
1999; 16
1999; 37
1995; 227
1996; 60
2003; 5
1998; 3
1998; 205
1998; 95
1998; 51
2003; 20
1996; 86
1989
2001; 98
Stockman (10.1002/jps.20219_bb0195) 1992; 31
Krishnan (10.1002/jps.20219_bb0090) 2002; 41
Fink (10.1002/jps.20219_bb0100) 1998; 3
Akers (10.1002/jps.20219_bb0010) 1984; 8
Belgaumi (10.1002/jps.20219_bb0020) 1999; 62
Gupta (10.1002/jps.20219_bb0060) 2003; 5
Fransson (10.1002/jps.20219_bb0040) 1997; 14
Kim (10.1002/jps.20219_bb0110) 2003; 278
Schreuder (10.1002/jps.20219_bb0205) 1995; 227
Webb (10.1002/jps.20219_bb0145) 2001; 98
Huyghues‐Despointes (10.1002/jps.20219_bb0175) 1999; 6
Uversky (10.1002/jps.20219_bb0215) 1996; 60
Remmele (10.1002/jps.20219_bb0050) 1998; 15
Dong (10.1002/jps.20219_bb0165) 1990; 29
Tan (10.1002/jps.20219_bb0030) 1993; 10
Arakawa (10.1002/jps.20219_bb0235) 1990; 27
Maa (10.1002/jps.20219_bb0035) 1996; 140
Kendrick (10.1002/jps.20219_bb0105) 1997; 94
Kim (10.1002/jps.20219_bb0160) 2001; 276
Chi (10.1002/jps.20219_bb0085) 2003; 20
Ratner (10.1002/jps.20219_bb0070) 1990; 39
Kim (10.1002/jps.20219_bb0130) 2002; 277
Rodrigues‐Silva (10.1002/jps.20219_bb0055) 1999; 37
Vigers (10.1002/jps.20219_bb0200) 1994; 269
Wetzel (10.1002/jps.20219_bb0095) 1996; 86
Chang (10.1002/jps.20219_bb0140) 1996; 71
Pace (10.1002/jps.20219_bb0190) 1989
Timasheff (10.1002/jps.20219_bb0230) 1998; 51
Bijma (10.1002/jps.20219_bb0225) 1998; 205
Lam (10.1002/jps.20219_bb0045) 1997; 14
Mach (10.1002/jps.20219_bb0210) 1994; 222
Wiseman (10.1002/jps.20219_bb0220) 1989; 179
Thornton (10.1002/jps.20219_bb0075) 1993; 50
Ragone (10.1002/jps.20219_bb0170) 1984; 23
Lee (10.1002/jps.20219_bb0150) 1981; 256
Strickland (10.1002/jps.20219_bb0185) 1974; 2
Batorova (10.1002/jps.20219_bb0025) 2002; 8
Tobler (10.1002/jps.20219_bb0135) 2004; 93
Narhi (10.1002/jps.20219_bb0080) 1999; 16
Kim (10.1002/jps.20219_bb0180) 2003; 12
Kendrick (10.1002/jps.20219_bb0115) 1998; 95
Kim (10.1002/jps.20219_bb0125) 2000; 275
Moore (10.1002/jps.20219_bb0065) 1980; 51
Timasheff (10.1002/jps.20219_bb0155) 1993; 22
Jorgensen (10.1002/jps.20219_bb0015) 1991; 25
Kendrick (10.1002/jps.20219_bb0120) 1998; 87
References_xml – volume: 71
  start-page: 3399
  year: 1996
  end-page: 3406
  ident: bb0140
  article-title: Formation of an active dimer during storage of interleukin‐1 receptor antagonist in aqueous solution
  publication-title: Biophys J
  contributor:
    fullname: Carpenter
– volume: 8
  start-page: 36
  year: 1984
  end-page: 46
  ident: bb0010
  article-title: Considerations in selecting antimicrobial agents for parenteral product development
  publication-title: Pharm Technol
  contributor:
    fullname: Akers
– volume: 31
  start-page: 5237
  year: 1992
  end-page: 5245
  ident: bb0195
  article-title: Secondary structure and topology of interleukin‐1 receptor antagonist protein determined by heteronuclear three‐dimensional NMR spectroscopy
  publication-title: Biochemistry
  contributor:
    fullname: Deibel
– volume: 277
  start-page: 27240
  year: 2002
  end-page: 27246
  ident: bb0130
  article-title: Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein: Insights into transition states from pressure, temperature and co‐solute studies
  publication-title: J Biol Chem
  contributor:
    fullname: Carpenter
– volume: 87
  start-page: 1069
  year: 1998
  end-page: 1080
  ident: bb0120
  article-title: Aggregation of recombinant human interferon‐gamma: Kinetics and structural transitions
  publication-title: J Pharm Sci
  contributor:
    fullname: Carpenter
– volume: 39
  start-page: 728
  year: 1990
  end-page: 733
  ident: bb0070
  article-title: Persistent cutaneous insulin allergy resulting from high‐molecular weight insulin aggregates
  publication-title: Diabetes
  contributor:
    fullname: Steiner
– volume: 5
  start-page: E8
  year: 2003
  ident: bb0060
  article-title: Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques
  publication-title: AAPS PharmSci
  contributor:
    fullname: Kaisheva
– volume: 51
  start-page: 355
  year: 1998
  end-page: 432
  ident: bb0230
  article-title: Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated
  publication-title: Adv Protein Chem
  contributor:
    fullname: Timasheff
– volume: 20
  start-page: 1325
  year: 2003
  end-page: 1336
  ident: bb0085
  article-title: Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation
  publication-title: Pharm Res
  contributor:
    fullname: Carpenter
– volume: 278
  start-page: 10842
  year: 2003
  end-page: 10850
  ident: bb0110
  article-title: Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation
  publication-title: J Biol Chem
  contributor:
    fullname: Carpenter
– volume: 179
  start-page: 131
  year: 1989
  end-page: 137
  ident: bb0220
  article-title: Rapid measurement of binding constants and heats of binding using a new titration calorimeter
  publication-title: Anal Biochem
  contributor:
    fullname: Lin
– volume: 140
  start-page: 155
  year: 1996
  end-page: 168
  ident: bb0035
  article-title: Aggregation of recombinant human growth hormone induced by phenolic compounds
  publication-title: Int J Pharm Sci
  contributor:
    fullname: Hsu
– volume: 86
  start-page: 699
  year: 1996
  end-page: 702
  ident: bb0095
  article-title: For protein misassembly, it's the “I” decade
  publication-title: Cell
  contributor:
    fullname: Wetzel
– volume: 222
  start-page: 323
  year: 1994
  end-page: 331
  ident: bb0210
  article-title: Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near‐ultraviolet second‐derivative spectroscopy
  publication-title: Anal Biochem
  contributor:
    fullname: Middaugh
– volume: 51
  start-page: 691
  year: 1980
  end-page: 697
  ident: bb0065
  article-title: Role of aggregated human growth hormone (Hgh) in development of antibodies to Hgh
  publication-title: J Clin Endocrin Metab
  contributor:
    fullname: Leppert
– volume: 93
  start-page: 1605
  year: 2004
  end-page: 1617
  ident: bb0135
  article-title: Benzyl alcohol‐induced destabilization of interferon‐γ: A study by hydrogen‐deuterium isotope exchange
  publication-title: J Pharm Sci
  contributor:
    fullname: Fernandez
– volume: 98
  start-page: 7259
  year: 2001
  end-page: 7264
  ident: bb0145
  article-title: Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High‐pressure and cosolute studies on recombinant human IFN‐γ
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Randolph
– volume: 23
  start-page: 1871
  year: 1984
  end-page: 1875
  ident: bb0170
  article-title: Determination of tyrosine exposure in proteins by second‐derivative spectroscopy
  publication-title: Biochemistry
  contributor:
    fullname: Irace
– volume: 95
  start-page: 14142
  year: 1998
  end-page: 14146
  ident: bb0115
  article-title: A transient expansion of the native state precedes aggregation of recombinant human interferon‐gamma
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Randolph
– volume: 12
  start-page: 1252
  year: 2003
  end-page: 1261
  ident: bb0180
  article-title: Effects of sucrose on conformational equilibria and fluctuations within the native‐state ensemble of proteins
  publication-title: Protein Sci
  contributor:
    fullname: Carpenter
– volume: 14
  start-page: 606
  year: 1997
  end-page: 612
  ident: bb0040
  article-title: Solvent effects on the solubility and physical stability of human insulin‐like growth factor I
  publication-title: Pharm Res
  contributor:
    fullname: Florin‐Robertsson
– volume: 14
  start-page: 725
  year: 1997
  end-page: 729
  ident: bb0045
  article-title: The effect of benzyl alcohol on recombinant human interferon‐γ
  publication-title: Pharm Res
  contributor:
    fullname: Nguyen
– volume: 15
  start-page: 200
  year: 1998
  end-page: 208
  ident: bb0050
  article-title: Interleukin‐1 receptor (IL‐1R) liquid formulation development using differential scanning calorimentry
  publication-title: Pharm Res
  contributor:
    fullname: Gombotz
– volume: 6
  start-page: 910
  year: 1999
  end-page: 912
  ident: bb0175
  article-title: Protein conformational stabilities can be determined from hydrogen exchange rates
  publication-title: Nat Struct Biol
  contributor:
    fullname: Pace
– volume: 41
  start-page: 6422
  year: 2002
  end-page: 6431
  ident: bb0090
  article-title: Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition
  publication-title: Biochemistry
  contributor:
    fullname: Carpenter
– volume: 62
  start-page: 13
  year: 1999
  end-page: 18
  ident: bb0020
  article-title: Stability and sterility of a recombinant Factor VIII concentrate prepared for continuous infusion administration
  publication-title: Am J Hematol
  contributor:
    fullname: Deitcher
– volume: 22
  start-page: 67
  year: 1993
  end-page: 97
  ident: bb0155
  article-title: The control of protein stability and association by weak interactions with water: How do solvents affect these processes?
  publication-title: Annu Rev Biophys Biomol Struct
  contributor:
    fullname: Timasheff
– volume: 227
  start-page: 838
  year: 1995
  end-page: 847
  ident: bb0205
  article-title: Refined crystal structure of the interleukin‐1 receptor antagonist. Presence of a disulfide link and a
  publication-title: Eur J Biochem
  contributor:
    fullname: Barrett
– volume: 94
  start-page: 11917
  year: 1997
  end-page: 11922
  ident: bb0105
  article-title: Preferential exclusion of sucrose from recombinant interleukin‐1 receptor antagonist: role in restricted conformational mobility and compaction of native state
  publication-title: Proc Natl Acad Sci USA
  contributor:
    fullname: Carpenter
– volume: 27
  start-page: 401
  year: 1990
  end-page: 415
  ident: bb0235
  article-title: The basis for toxicity of certain cryoprotectants: A hypothesis
  publication-title: Cryobiology
  contributor:
    fullname: Crowe
– volume: 29
  start-page: 3303
  year: 1990
  end-page: 3308
  ident: bb0165
  article-title: Protein secondary structures in water from second‐derivative amide I infrared spectra
  publication-title: Biochemistry
  contributor:
    fullname: Caughey
– volume: 16
  start-page: 799
  year: 1999
  end-page: 807
  ident: bb0080
  article-title: Reversibility of heat‐induced denaturation of the recombinant human megakaryocyte growth and development factor
  publication-title: Pharm Res
  contributor:
    fullname: Arakawa
– volume: 275
  start-page: 1570
  year: 2000
  end-page: 1574
  ident: bb0125
  article-title: Thermodynamic modulation of light chain amyloid fibril formation
  publication-title: J Biol Chem
  contributor:
    fullname: Carpenter
– volume: 256
  start-page: 7193
  year: 1981
  end-page: 7201
  ident: bb0150
  article-title: The stabilization of proteins by sucrose
  publication-title: J Biol Chem
  contributor:
    fullname: Timasheff
– volume: 269
  start-page: 12874
  year: 1994
  end-page: 12879
  ident: bb0200
  article-title: X‐ray structure of interleukin‐1 receptor antagonist at 2.0‐A resolution
  publication-title: J Biol Chem
  contributor:
    fullname: Brandhuber
– volume: 10
  start-page: 1238
  year: 1993
  end-page: 1242
  ident: bb0030
  article-title: Transforming growth factor‐alpha (TGF‐alpha) in a semisolid dosage form: Preservative and vehicle selection
  publication-title: Pharm Res
  contributor:
    fullname: Patel
– volume: 3
  start-page: R9
  year: 1998
  end-page: R23
  ident: bb0100
  article-title: Protein aggregation: Folding aggregates, inclusion bodies and amyloid
  publication-title: Fold Des
  contributor:
    fullname: Fink
– volume: 2
  start-page: 113
  year: 1974
  end-page: 175
  ident: bb0185
  article-title: Aromatic contributions to circular dichroism spectra of proteins
  publication-title: CRC Crit Rev Biochem
  contributor:
    fullname: Strickland
– volume: 37
  start-page: 33
  year: 1999
  end-page: 45
  ident: bb0055
  article-title: Thermal stability studies of hyperimmune horse antivenoms
  publication-title: Toxicon
  contributor:
    fullname: Santoro
– volume: 50
  start-page: 135
  year: 1993
  end-page: 136
  ident: bb0075
  article-title: Safety of intravenous immunoglobulin
  publication-title: Arch Neurol
  contributor:
    fullname: Ballow
– volume: 276
  start-page: 1626
  year: 2001
  end-page: 1633
  ident: bb0160
  article-title: Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains
  publication-title: J Biol Chem
  contributor:
    fullname: Carpenter
– volume: 25
  start-page: 585
  year: 1991
  end-page: 588
  ident: bb0015
  article-title: Patient acceptance of Nordiject: A new drug delivery system for growth hormone
  publication-title: DICP: Ann Pharmacother
  contributor:
    fullname: Jorgensen
– volume: 8
  start-page: 170
  year: 2002
  end-page: 177
  ident: bb0025
  article-title: Continuous infusion of coagulation factors
  publication-title: Haemophilia
  contributor:
    fullname: Martinowitz
– start-page: 311
  year: 1989
  end-page: 330
  ident: bb0190
  article-title: Measuring the conformational stability of a protein
  publication-title: Protein structure: A practical approach
  contributor:
    fullname: Thomson
– volume: 205
  start-page: 245
  year: 1998
  end-page: 256
  ident: bb0225
  article-title: Effect of counterion structure on micellar growth of alkylpyridinium surfactants in aqueous solution
  publication-title: J Colloid Interface Sci
  contributor:
    fullname: Engberts
– volume: 60
  start-page: 79
  year: 1996
  end-page: 88
  ident: bb0215
  article-title: Use of fluorescence decay times of 8‐ANS–protein complexes to study the conformational transitions in proteins which unfold through the molten globule state
  publication-title: Biophys Chem
  contributor:
    fullname: Lober
– volume: 5
  start-page: E8
  year: 2003
  article-title: Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques
  publication-title: AAPS PharmSci
– volume: 14
  start-page: 725
  year: 1997
  end-page: 729
  article-title: The effect of benzyl alcohol on recombinant human interferon‐γ
  publication-title: Pharm Res
– volume: 31
  start-page: 5237
  year: 1992
  end-page: 5245
  article-title: Secondary structure and topology of interleukin‐1 receptor antagonist protein determined by heteronuclear three‐dimensional NMR spectroscopy
  publication-title: Biochemistry
– volume: 41
  start-page: 6422
  year: 2002
  end-page: 6431
  article-title: Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition
  publication-title: Biochemistry
– volume: 140
  start-page: 155
  year: 1996
  end-page: 168
  article-title: Aggregation of recombinant human growth hormone induced by phenolic compounds
  publication-title: Int J Pharm Sci
– volume: 2
  start-page: 113
  year: 1974
  end-page: 175
  article-title: Aromatic contributions to circular dichroism spectra of proteins
  publication-title: CRC Crit Rev Biochem
– volume: 205
  start-page: 245
  year: 1998
  end-page: 256
  article-title: Effect of counterion structure on micellar growth of alkylpyridinium surfactants in aqueous solution
  publication-title: J Colloid Interface Sci
– volume: 16
  start-page: 799
  year: 1999
  end-page: 807
  article-title: Reversibility of heat‐induced denaturation of the recombinant human megakaryocyte growth and development factor
  publication-title: Pharm Res
– volume: 14
  start-page: 606
  year: 1997
  end-page: 612
  article-title: Solvent effects on the solubility and physical stability of human insulin‐like growth factor I
  publication-title: Pharm Res
– volume: 222
  start-page: 323
  year: 1994
  end-page: 331
  article-title: Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near‐ultraviolet second‐derivative spectroscopy
  publication-title: Anal Biochem
– volume: 98
  start-page: 7259
  year: 2001
  end-page: 7264
  article-title: Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High‐pressure and cosolute studies on recombinant human IFN‐γ
  publication-title: Proc Natl Acad Sci USA
– volume: 256
  start-page: 7193
  year: 1981
  end-page: 7201
  article-title: The stabilization of proteins by sucrose
  publication-title: J Biol Chem
– volume: 275
  start-page: 1570
  year: 2000
  end-page: 1574
  article-title: Thermodynamic modulation of light chain amyloid fibril formation
  publication-title: J Biol Chem
– volume: 269
  start-page: 12874
  year: 1994
  end-page: 12879
  article-title: X‐ray structure of interleukin‐1 receptor antagonist at 2.0‐A resolution
  publication-title: J Biol Chem
– volume: 60
  start-page: 79
  year: 1996
  end-page: 88
  article-title: Use of fluorescence decay times of 8‐ANS–protein complexes to study the conformational transitions in proteins which unfold through the molten globule state
  publication-title: Biophys Chem
– volume: 278
  start-page: 10842
  year: 2003
  end-page: 10850
  article-title: Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation
  publication-title: J Biol Chem
– volume: 8
  start-page: 170
  year: 2002
  end-page: 177
  article-title: Continuous infusion of coagulation factors
  publication-title: Haemophilia
– volume: 3
  start-page: R9
  year: 1998
  end-page: R23
  article-title: Protein aggregation: Folding aggregates, inclusion bodies and amyloid
  publication-title: Fold Des
– volume: 179
  start-page: 131
  year: 1989
  end-page: 137
  article-title: Rapid measurement of binding constants and heats of binding using a new titration calorimeter
  publication-title: Anal Biochem
– volume: 50
  start-page: 135
  year: 1993
  end-page: 136
  article-title: Safety of intravenous immunoglobulin
  publication-title: Arch Neurol
– volume: 276
  start-page: 1626
  year: 2001
  end-page: 1633
  article-title: Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains
  publication-title: J Biol Chem
– volume: 22
  start-page: 67
  year: 1993
  end-page: 97
  article-title: The control of protein stability and association by weak interactions with water: How do solvents affect these processes?
  publication-title: Annu Rev Biophys Biomol Struct
– volume: 20
  start-page: 1325
  year: 2003
  end-page: 1336
  article-title: Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation
  publication-title: Pharm Res
– volume: 95
  start-page: 14142
  year: 1998
  end-page: 14146
  article-title: A transient expansion of the native state precedes aggregation of recombinant human interferon‐gamma
  publication-title: Proc Natl Acad Sci USA
– start-page: 311
  year: 1989
  end-page: 330
– volume: 29
  start-page: 3303
  year: 1990
  end-page: 3308
  article-title: Protein secondary structures in water from second‐derivative amide I infrared spectra
  publication-title: Biochemistry
– volume: 39
  start-page: 728
  year: 1990
  end-page: 733
  article-title: Persistent cutaneous insulin allergy resulting from high‐molecular weight insulin aggregates
  publication-title: Diabetes
– volume: 277
  start-page: 27240
  year: 2002
  end-page: 27246
  article-title: Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein: Insights into transition states from pressure, temperature and co‐solute studies
  publication-title: J Biol Chem
– volume: 10
  start-page: 1238
  year: 1993
  end-page: 1242
  article-title: Transforming growth factor‐alpha (TGF‐alpha) in a semisolid dosage form: Preservative and vehicle selection
  publication-title: Pharm Res
– volume: 12
  start-page: 1252
  year: 2003
  end-page: 1261
  article-title: Effects of sucrose on conformational equilibria and fluctuations within the native‐state ensemble of proteins
  publication-title: Protein Sci
– volume: 27
  start-page: 401
  year: 1990
  end-page: 415
  article-title: The basis for toxicity of certain cryoprotectants: A hypothesis
  publication-title: Cryobiology
– volume: 15
  start-page: 200
  year: 1998
  end-page: 208
  article-title: Interleukin‐1 receptor (IL‐1R) liquid formulation development using differential scanning calorimentry
  publication-title: Pharm Res
– volume: 86
  start-page: 699
  year: 1996
  end-page: 702
  article-title: For protein misassembly, it's the “I” decade
  publication-title: Cell
– volume: 8
  start-page: 36
  year: 1984
  end-page: 46
  article-title: Considerations in selecting antimicrobial agents for parenteral product development
  publication-title: Pharm Technol
– volume: 62
  start-page: 13
  year: 1999
  end-page: 18
  article-title: Stability and sterility of a recombinant Factor VIII concentrate prepared for continuous infusion administration
  publication-title: Am J Hematol
– volume: 94
  start-page: 11917
  year: 1997
  end-page: 11922
  article-title: Preferential exclusion of sucrose from recombinant interleukin‐1 receptor antagonist: role in restricted conformational mobility and compaction of native state
  publication-title: Proc Natl Acad Sci USA
– volume: 25
  start-page: 585
  year: 1991
  end-page: 588
  article-title: Patient acceptance of Nordiject: A new drug delivery system for growth hormone
  publication-title: DICP: Ann Pharmacother
– volume: 51
  start-page: 691
  year: 1980
  end-page: 697
  article-title: Role of aggregated human growth hormone (Hgh) in development of antibodies to Hgh
  publication-title: J Clin Endocrin Metab
– volume: 87
  start-page: 1069
  year: 1998
  end-page: 1080
  article-title: Aggregation of recombinant human interferon‐gamma: Kinetics and structural transitions
  publication-title: J Pharm Sci
– volume: 37
  start-page: 33
  year: 1999
  end-page: 45
  article-title: Thermal stability studies of hyperimmune horse antivenoms
  publication-title: Toxicon
– volume: 51
  start-page: 355
  year: 1998
  end-page: 432
  article-title: Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated
  publication-title: Adv Protein Chem
– volume: 23
  start-page: 1871
  year: 1984
  end-page: 1875
  article-title: Determination of tyrosine exposure in proteins by second‐derivative spectroscopy
  publication-title: Biochemistry
– volume: 227
  start-page: 838
  year: 1995
  end-page: 847
  article-title: Refined crystal structure of the interleukin‐1 receptor antagonist. Presence of a disulfide link and a ‐proline
  publication-title: Eur J Biochem
– volume: 6
  start-page: 910
  year: 1999
  end-page: 912
  article-title: Protein conformational stabilities can be determined from hydrogen exchange rates
  publication-title: Nat Struct Biol
– volume: 71
  start-page: 3399
  year: 1996
  end-page: 3406
  article-title: Formation of an active dimer during storage of interleukin‐1 receptor antagonist in aqueous solution
  publication-title: Biophys J
– volume: 93
  start-page: 1605
  year: 2004
  end-page: 1617
  article-title: Benzyl alcohol‐induced destabilization of interferon‐γ: A study by hydrogen‐deuterium isotope exchange
  publication-title: J Pharm Sci
– volume: 256
  start-page: 7193
  year: 1981
  ident: 10.1002/jps.20219_bb0150
  article-title: The stabilization of proteins by sucrose
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(19)68947-7
  contributor:
    fullname: Lee
– volume: 94
  start-page: 11917
  year: 1997
  ident: 10.1002/jps.20219_bb0105
  article-title: Preferential exclusion of sucrose from recombinant interleukin‐1 receptor antagonist: role in restricted conformational mobility and compaction of native state
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.94.22.11917
  contributor:
    fullname: Kendrick
– volume: 39
  start-page: 728
  year: 1990
  ident: 10.1002/jps.20219_bb0070
  article-title: Persistent cutaneous insulin allergy resulting from high‐molecular weight insulin aggregates
  publication-title: Diabetes
  doi: 10.2337/diab.39.6.728
  contributor:
    fullname: Ratner
– volume: 23
  start-page: 1871
  year: 1984
  ident: 10.1002/jps.20219_bb0170
  article-title: Determination of tyrosine exposure in proteins by second‐derivative spectroscopy
  publication-title: Biochemistry
  doi: 10.1021/bi00303a044
  contributor:
    fullname: Ragone
– volume: 31
  start-page: 5237
  year: 1992
  ident: 10.1002/jps.20219_bb0195
  article-title: Secondary structure and topology of interleukin‐1 receptor antagonist protein determined by heteronuclear three‐dimensional NMR spectroscopy
  publication-title: Biochemistry
  doi: 10.1021/bi00138a001
  contributor:
    fullname: Stockman
– volume: 10
  start-page: 1238
  year: 1993
  ident: 10.1002/jps.20219_bb0030
  article-title: Transforming growth factor‐alpha (TGF‐alpha) in a semisolid dosage form: Preservative and vehicle selection
  publication-title: Pharm Res
  doi: 10.1023/A:1018940907187
  contributor:
    fullname: Tan
– volume: 14
  start-page: 606
  year: 1997
  ident: 10.1002/jps.20219_bb0040
  article-title: Solvent effects on the solubility and physical stability of human insulin‐like growth factor I
  publication-title: Pharm Res
  doi: 10.1023/A:1012101027814
  contributor:
    fullname: Fransson
– volume: 275
  start-page: 1570
  year: 2000
  ident: 10.1002/jps.20219_bb0125
  article-title: Thermodynamic modulation of light chain amyloid fibril formation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.275.3.1570
  contributor:
    fullname: Kim
– volume: 50
  start-page: 135
  year: 1993
  ident: 10.1002/jps.20219_bb0075
  article-title: Safety of intravenous immunoglobulin
  publication-title: Arch Neurol
  doi: 10.1001/archneur.1993.00540020013009
  contributor:
    fullname: Thornton
– volume: 22
  start-page: 67
  year: 1993
  ident: 10.1002/jps.20219_bb0155
  article-title: The control of protein stability and association by weak interactions with water: How do solvents affect these processes?
  publication-title: Annu Rev Biophys Biomol Struct
  doi: 10.1146/annurev.bb.22.060193.000435
  contributor:
    fullname: Timasheff
– volume: 227
  start-page: 838
  year: 1995
  ident: 10.1002/jps.20219_bb0205
  article-title: Refined crystal structure of the interleukin‐1 receptor antagonist. Presence of a disulfide link and a cis‐proline
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1995.tb20209.x
  contributor:
    fullname: Schreuder
– volume: 37
  start-page: 33
  year: 1999
  ident: 10.1002/jps.20219_bb0055
  article-title: Thermal stability studies of hyperimmune horse antivenoms
  publication-title: Toxicon
  doi: 10.1016/S0041-0101(97)00101-3
  contributor:
    fullname: Rodrigues‐Silva
– volume: 222
  start-page: 323
  year: 1994
  ident: 10.1002/jps.20219_bb0210
  article-title: Simultaneous monitoring of the environment of tryptophan, tyrosine, and phenylalanine residues in proteins by near‐ultraviolet second‐derivative spectroscopy
  publication-title: Anal Biochem
  doi: 10.1006/abio.1994.1499
  contributor:
    fullname: Mach
– volume: 25
  start-page: 585
  year: 1991
  ident: 10.1002/jps.20219_bb0015
  article-title: Patient acceptance of Nordiject: A new drug delivery system for growth hormone
  publication-title: DICP: Ann Pharmacother
  doi: 10.1177/106002809102500603
  contributor:
    fullname: Jorgensen
– volume: 205
  start-page: 245
  year: 1998
  ident: 10.1002/jps.20219_bb0225
  article-title: Effect of counterion structure on micellar growth of alkylpyridinium surfactants in aqueous solution
  publication-title: J Colloid Interface Sci
  doi: 10.1006/jcis.1998.5687
  contributor:
    fullname: Bijma
– volume: 3
  start-page: R9
  year: 1998
  ident: 10.1002/jps.20219_bb0100
  article-title: Protein aggregation: Folding aggregates, inclusion bodies and amyloid
  publication-title: Fold Des
  doi: 10.1016/S1359-0278(98)00002-9
  contributor:
    fullname: Fink
– volume: 29
  start-page: 3303
  year: 1990
  ident: 10.1002/jps.20219_bb0165
  article-title: Protein secondary structures in water from second‐derivative amide I infrared spectra
  publication-title: Biochemistry
  doi: 10.1021/bi00465a022
  contributor:
    fullname: Dong
– volume: 278
  start-page: 10842
  year: 2003
  ident: 10.1002/jps.20219_bb0110
  article-title: Congo red populates partially unfolded states of an amyloidogenic protein to enhance aggregation and amyloid fibril formation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M212540200
  contributor:
    fullname: Kim
– volume: 269
  start-page: 12874
  year: 1994
  ident: 10.1002/jps.20219_bb0200
  article-title: X‐ray structure of interleukin‐1 receptor antagonist at 2.0‐A resolution
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)99957-6
  contributor:
    fullname: Vigers
– volume: 60
  start-page: 79
  year: 1996
  ident: 10.1002/jps.20219_bb0215
  article-title: Use of fluorescence decay times of 8‐ANS–protein complexes to study the conformational transitions in proteins which unfold through the molten globule state
  publication-title: Biophys Chem
  doi: 10.1016/0301-4622(96)00009-9
  contributor:
    fullname: Uversky
– volume: 87
  start-page: 1069
  year: 1998
  ident: 10.1002/jps.20219_bb0120
  article-title: Aggregation of recombinant human interferon‐gamma: Kinetics and structural transitions
  publication-title: J Pharm Sci
  doi: 10.1021/js9801384
  contributor:
    fullname: Kendrick
– volume: 12
  start-page: 1252
  year: 2003
  ident: 10.1002/jps.20219_bb0180
  article-title: Effects of sucrose on conformational equilibria and fluctuations within the native‐state ensemble of proteins
  publication-title: Protein Sci
  doi: 10.1110/ps.0242603
  contributor:
    fullname: Kim
– volume: 51
  start-page: 355
  year: 1998
  ident: 10.1002/jps.20219_bb0230
  article-title: Control of protein stability and reactions by weakly interacting cosolvents: The simplicity of the complicated
  publication-title: Adv Protein Chem
  doi: 10.1016/S0065-3233(08)60656-7
  contributor:
    fullname: Timasheff
– volume: 5
  start-page: E8
  year: 2003
  ident: 10.1002/jps.20219_bb0060
  article-title: Development of a multidose formulation for a humanized monoclonal antibody using experimental design techniques
  publication-title: AAPS PharmSci
  doi: 10.1208/ps050208
  contributor:
    fullname: Gupta
– volume: 51
  start-page: 691
  year: 1980
  ident: 10.1002/jps.20219_bb0065
  article-title: Role of aggregated human growth hormone (Hgh) in development of antibodies to Hgh
  publication-title: J Clin Endocrin Metab
  doi: 10.1210/jcem-51-4-691
  contributor:
    fullname: Moore
– volume: 93
  start-page: 1605
  year: 2004
  ident: 10.1002/jps.20219_bb0135
  article-title: Benzyl alcohol‐induced destabilization of interferon‐γ: A study by hydrogen‐deuterium isotope exchange
  publication-title: J Pharm Sci
  doi: 10.1002/jps.10589
  contributor:
    fullname: Tobler
– volume: 86
  start-page: 699
  year: 1996
  ident: 10.1002/jps.20219_bb0095
  article-title: For protein misassembly, it's the “I” decade
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)80143-9
  contributor:
    fullname: Wetzel
– volume: 2
  start-page: 113
  year: 1974
  ident: 10.1002/jps.20219_bb0185
  article-title: Aromatic contributions to circular dichroism spectra of proteins
  publication-title: CRC Crit Rev Biochem
  doi: 10.3109/10409237409105445
  contributor:
    fullname: Strickland
– volume: 179
  start-page: 131
  year: 1989
  ident: 10.1002/jps.20219_bb0220
  article-title: Rapid measurement of binding constants and heats of binding using a new titration calorimeter
  publication-title: Anal Biochem
  doi: 10.1016/0003-2697(89)90213-3
  contributor:
    fullname: Wiseman
– volume: 16
  start-page: 799
  year: 1999
  ident: 10.1002/jps.20219_bb0080
  article-title: Reversibility of heat‐induced denaturation of the recombinant human megakaryocyte growth and development factor
  publication-title: Pharm Res
  doi: 10.1023/A:1018893115557
  contributor:
    fullname: Narhi
– volume: 6
  start-page: 910
  year: 1999
  ident: 10.1002/jps.20219_bb0175
  article-title: Protein conformational stabilities can be determined from hydrogen exchange rates
  publication-title: Nat Struct Biol
  doi: 10.1038/13273
  contributor:
    fullname: Huyghues‐Despointes
– volume: 140
  start-page: 155
  year: 1996
  ident: 10.1002/jps.20219_bb0035
  article-title: Aggregation of recombinant human growth hormone induced by phenolic compounds
  publication-title: Int J Pharm Sci
  doi: 10.1016/0378-5173(96)04577-2
  contributor:
    fullname: Maa
– start-page: 311
  year: 1989
  ident: 10.1002/jps.20219_bb0190
  article-title: Measuring the conformational stability of a protein
  contributor:
    fullname: Pace
– volume: 8
  start-page: 170
  year: 2002
  ident: 10.1002/jps.20219_bb0025
  article-title: Continuous infusion of coagulation factors
  publication-title: Haemophilia
  doi: 10.1046/j.1365-2516.2002.00635.x
  contributor:
    fullname: Batorova
– volume: 71
  start-page: 3399
  year: 1996
  ident: 10.1002/jps.20219_bb0140
  article-title: Formation of an active dimer during storage of interleukin‐1 receptor antagonist in aqueous solution
  publication-title: Biophys J
  doi: 10.1016/S0006-3495(96)79534-6
  contributor:
    fullname: Chang
– volume: 14
  start-page: 725
  year: 1997
  ident: 10.1002/jps.20219_bb0045
  article-title: The effect of benzyl alcohol on recombinant human interferon‐γ
  publication-title: Pharm Res
  doi: 10.1023/A:1012190120061
  contributor:
    fullname: Lam
– volume: 15
  start-page: 200
  year: 1998
  ident: 10.1002/jps.20219_bb0050
  article-title: Interleukin‐1 receptor (IL‐1R) liquid formulation development using differential scanning calorimentry
  publication-title: Pharm Res
  doi: 10.1023/A:1011902215383
  contributor:
    fullname: Remmele
– volume: 62
  start-page: 13
  year: 1999
  ident: 10.1002/jps.20219_bb0020
  article-title: Stability and sterility of a recombinant Factor VIII concentrate prepared for continuous infusion administration
  publication-title: Am J Hematol
  doi: 10.1002/(SICI)1096-8652(199909)62:1<13::AID-AJH3>3.0.CO;2-X
  contributor:
    fullname: Belgaumi
– volume: 41
  start-page: 6422
  year: 2002
  ident: 10.1002/jps.20219_bb0090
  article-title: Aggregation of granulocyte colony stimulating factor under physiological conditions: Characterization and thermodynamic inhibition
  publication-title: Biochemistry
  doi: 10.1021/bi012006m
  contributor:
    fullname: Krishnan
– volume: 277
  start-page: 27240
  year: 2002
  ident: 10.1002/jps.20219_bb0130
  article-title: Kinetics and energetics of assembly, nucleation, and growth of aggregates and fibrils for an amyloidogenic protein: Insights into transition states from pressure, temperature and co‐solute studies
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M202492200
  contributor:
    fullname: Kim
– volume: 20
  start-page: 1325
  year: 2003
  ident: 10.1002/jps.20219_bb0085
  article-title: Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation
  publication-title: Pharm Res
  doi: 10.1023/A:1025771421906
  contributor:
    fullname: Chi
– volume: 8
  start-page: 36
  year: 1984
  ident: 10.1002/jps.20219_bb0010
  article-title: Considerations in selecting antimicrobial agents for parenteral product development
  publication-title: Pharm Technol
  contributor:
    fullname: Akers
– volume: 95
  start-page: 14142
  year: 1998
  ident: 10.1002/jps.20219_bb0115
  article-title: A transient expansion of the native state precedes aggregation of recombinant human interferon‐gamma
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.95.24.14142
  contributor:
    fullname: Kendrick
– volume: 98
  start-page: 7259
  year: 2001
  ident: 10.1002/jps.20219_bb0145
  article-title: Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High‐pressure and cosolute studies on recombinant human IFN‐γ
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.131194798
  contributor:
    fullname: Webb
– volume: 276
  start-page: 1626
  year: 2001
  ident: 10.1002/jps.20219_bb0160
  article-title: Counteracting effects of renal solutes on amyloid fibril formation by immunoglobulin light chains
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M007766200
  contributor:
    fullname: Kim
– volume: 27
  start-page: 401
  year: 1990
  ident: 10.1002/jps.20219_bb0235
  article-title: The basis for toxicity of certain cryoprotectants: A hypothesis
  publication-title: Cryobiology
  doi: 10.1016/0011-2240(90)90017-X
  contributor:
    fullname: Arakawa
SSID ssj0006055
Score 2.0651755
Snippet Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin‐1 receptor antagonist (rhIL‐1ra) in...
Benzyl alcohol, an antimicrobial preservative, accelerates aggregation and precipitation of recombinant human interleukin-1 receptor antagonist (rhIL-1ra) in...
SourceID proquest
crossref
pubmed
pascalfrancis
wiley
istex
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 3076
SubjectTerms benzyl alcohol
Benzyl Alcohol - pharmacology
Biological and medical sciences
General pharmacology
Humans
Interleukin 1 Receptor Antagonist Protein
Medical sciences
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
protein aggregation
Receptors, Interleukin-1 - antagonists & inhibitors
Receptors, Interleukin-1 - metabolism
Recombinant Proteins - analysis
Recombinant Proteins - metabolism
Sialoglycoproteins - analysis
Sialoglycoproteins - metabolism
Solutions
sucrose
Water - metabolism
Title Mechanism for benzyl alcohol‐induced aggregation of recombinant human interleukin‐1 receptor antagonist in aqueous solution
URI https://dx.doi.org/10.1002/jps.20219
https://api.istex.fr/ark:/67375/WNG-GHHSS47G-2/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjps.20219
https://www.ncbi.nlm.nih.gov/pubmed/15514986
https://search.proquest.com/docview/67043038
Volume 93
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3fa9swEMeP0r7sZVv30_vRiTHCHuI2tuXYZk9jrAmFlrC0rA8DIclySNM6IU5g6cv2J-xv3F-yOymO6WhhDL_k4SSs8538OUf6CuBdmqq4I0lj3_DQ5zwq_FQm2s-UynSSBpHs0gbn45Nu_4wfncfnW_Ch3gvj9CE2H9woM-x8TQkuVXXQiIZezEhtO7SSnySkR0D0pZGOQkyPN0rhWATVqkKd8GDT8q530Q55-Dstk5QVeqpwR1zcxqA3kda-kw4fwLd6NG4pymR_uVD7-vovocf_HO5DuL9mVfbRBdcubJnyEbQGTux61Wanzd6tqs1abNDIYK8ew49jQ7uKx9UVQzBmypTXq0sm3ZG8v3_-Gpc5hlXO5AhL_pENEDYtGFXoV8quz2H2AEFGihbzS7OcjEtsFpCFmS2wSzSRoylJ_6INk-iz6bJidTI9gbPDz6ef-v76uAdfI7NlfpGZIMcKS-ecF4EqEAZ5LpXEmifMFRaqSeGQNMYLwTEpOKnLmazDkQIRtZ7CdjktzXNgidK5UTSZac0NMphCSxPoKIkl8m3kwdv6wYuZU_UQTr85FOhoYR3tQbsOCbHGEYcZAp_ObeYtGzabDuV8Qqvmklh8PemJXr8_HPKkJ0IP9m7EVXMHXZxgkfg8eFMHmsBkp39wZEkexO5Ioi1KPXjm4q9pS-SbpV0P3tsountY4mgwtD9e_LvpS7hXC1x2glewvZgvzWuEsYXas1n3B5QGMxI
link.rule.ids 315,786,790,1382,27957,27958,46329,46753
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NbtNAEMdHVXuAC5RvU2hXCEUc4ja217EtcUGIJpQmikgqekGrXXsdhbROlA-J9AKPwDPyJMzsxrGKWgkhX3KYXXnHM-v_OLu_BXgdxypsSGLsa-67nAe5G8sodROlkjSKvUA2aYNzp9tsn_GT8_B8C96We2EsH2LzwY0yw8zXlOD0QfqoooZ-mxJu2yfm5w6me2gKqs8VPAqFerhhhWMZVHKFGv7Rpultb6Md8vF3Wigp5-ir3B5ycZMKvS5qzVvp-D58LcdjF6OMD5cLdZhe_YV6_N8B78K9tVxl72x8PYAtXTyEWs_yrld1Nqi2b83rrMZ6FQl79Qh-dDRtLB7NLxlqY6Z0cbW6YNKeyvv7569RkWFkZUwOseofmhhhk5xRkX6pzBIdZs4QZAS1mF3o5XhUYDOPLPR0gV2iiRxOiP6LNkyi0ybLOSvz6TGcHX8YvG-76xMf3BRlW-LmifYyLLLSjPPcUznqQZ5JJbHs8TOFtWqUW1Ua4oXaMco5AeZ00uAoBFFtPYHtYlLoZ8AilWZa0XyWplyjDFNoqb00iEKJEjdw4FX55MXUgj2ERTj7Ah0tjKMdqJcxIdaKxCoNgY_nJvOaiZtNh3I2poVzUSi-dFui1W73-zxqCd-B_WuBVd1BE-dYFH0OHJSRJjDf6U8cWZAHsTuitAWxA09tAFZtSfwmcdOBNyaMbh-WOOn1zY_n_256AHfag86pOP3Y_bQHd0veZcN7AduL2VK_RG22UPsmBf8Aqyg3NA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEB1VrYS4QPk2hXaFUMQhbmN7HdvihChJKDSKSCt6qLTatddRSOtE-ZBIL_AT-I38EmZ241hFrYSQLz7Mrryzb9Zv7Nm3AK_jWIUNSRr7mvsu50HuxjJK3USpJI1iL5BN2uB83G12TvnRWXi2AW_LvTBWH2L9wY0iw6zXFOCTLD-oREO_TUht2yfJzy3eDHyC9OGXSjsKeXq4lgrHLKiUFWr4B-umt72MtsjF36lOUs7QVbk94-ImEnqd05qXUus-nJfDsbUoo_3FXO2nV38pPf7neLfh3oqssncWXQ9gQxcPodazatfLOjupNm_N6qzGepUO9vIR_DjWtK14OLtkyIyZ0sXV8oJJeybv75-_hkWGuMqYHGDOPzAIYeOcUYp-qUyBDjMnCDKStJhe6MVoWGAzjyz0ZI5dookcjEn7F22YRJ-NFzNWRtNjOG19OHnfcVfnPbgpkrbEzRPtZZhipRnnuadyZIM8k0pi0uNnCjPVKLecNMQLmWOUc5KX00mDIw1ErvUENotxoZ8Bi1SaaUWrWZpyjSRMoaX20iAKJRLcwIFX5cSLiZX1EFbA2RfoaGEc7UC9hIRY8RHLMwTOzk3mNQObdYdyOqKyuSgUX7tt0e50-n0etYXvwO41XFVP0MQVFimfA3sl0ARGO_3CkQV5ELsjjbYgduCpxV_VlqhvEjcdeGNQdPuwxFGvb26e_7vpHtzpHbbE54_dTztwtxS7bHgvYHM-XeiXSMzmatcE4B_qXDXj
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanism+for+benzyl+alcohol-induced+aggregation+of+recombinant+human+interleukin-1+receptor+antagonist+in+aqueous+solution&rft.jtitle=Journal+of+pharmaceutical+sciences&rft.au=Zhang%2C+Ye&rft.au=Roy%2C+Shouvik&rft.au=Jones%2C+Latoya+S&rft.au=Krishnan%2C+Sampathkumar&rft.date=2004-12-01&rft.issn=0022-3549&rft.volume=93&rft.issue=12&rft.spage=3076&rft_id=info:doi/10.1002%2Fjps.20219&rft_id=info%3Apmid%2F15514986&rft.externalDocID=15514986
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3549&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3549&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3549&client=summon